|
41 |
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
Enthalten in Neurological research and practice Bd. 4, 23.5.2022, Nr. 1, date:12.2022: 1-7
|
|
|
|
42 |
Brain Tumor Networks in Diffuse Glioma
Enthalten in Neurotherapeutics Bd. 19, 10.11.2022, Nr. 6, date:10.2022: 1832-1843
|
|
|
|
43 |
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Enthalten in Acta neuropathologica Bd. 140, 8.7.2020, Nr. 3, date:9.2020: 409-413
|
|
|
|
44 |
Chemotherapy for intracranial ependymoma in adults
Enthalten in BMC cancer Bd. 16, 23.4.2016, Nr. 1, date:12.2016: 1-12
|
|
|
|
45 |
Concurrent gliomas in patients with multiple sclerosis
Enthalten in Communications medicine Bd. 3, 18.12.2023, Nr. 1, date:12.2023: 1-9
|
|
|
|
46 |
Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis
Enthalten in Nature Communications Bd. 15, 10.9.2024, Nr. 1, date:12.2024: 1-21
|
|
|
|
47 |
Deep-learning based detection of vessel occlusions on CT-angiography in patients with suspected acute ischemic stroke
Enthalten in Nature Communications Bd. 14, 15.8.2023, Nr. 1, date:12.2023: 1-15
|
|
|
|
48 |
DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas
Enthalten in Nature Communications Bd. 13, 29.7.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
49 |
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
Enthalten in Acta Neuropathologica Communications Bd. 7, 25.4.2019, Nr. 1, date:12.2019: 1-18
|
|
|
|
50 |
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
Enthalten in Acta neuropathologica Bd. 144, 4.6.2022, Nr. 1, date:7.2022: 129-142
|
|
Administration
